| Rates of psychotropic medication use over time among youth in child welfare/child protective services. | |
| | |
MedLine Citation:
|
PMID: 20415609 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: The aim of this study was to examine rates of psychotropic medication use over time among a national probability sample of youths involved with child welfare/child protective services (CW/CPS) in the National Survey of Child and Adolescent Well-Being (NSCAW). METHODS: Growth mixture modeling was used to classify 2,521 youths into groups based on individual medication use trajectories. Determinants associated with groupings were examined using logistic regression. RESULTS: Overall, 22% of youths used medications over 3 years. Three groups were identified: (1) Low medication use (85%, n = 2,057), where medication was used rarely or never; (2) increasing medication use, where medication was commonly started after investigation (4%, n = 148); and (3) high medication use, where medication use was endorsed over multiple study waves (12%, n = 316). On multivariate modeling, physical abuse predicted membership in the increasing-use group (reference group, low use); Caucasian (versus African American) and need predicted membership in the high-use group (reference group, low use). Male gender was associated with membership in both the increasing-use and high-use groups (reference group, low use). Age and abuse type (physical abuse, neglect) demonstrated complex relationships with group membership. CONCLUSIONS: Psychotropic medication use trajectories for children in child welfare vary and are best understood when disaggregated into distinct subpopulations. |
| | |
Authors:
|
Laurel K Leslie; Ramesh Raghavan; Jinjin Zhang; Gregory A Aarons |
Related Documents
:
|
7053489 - Rural health care: opportunities for established group practices. 17310049 - The effectiveness of a primer to help people understand risk: two randomized trials in ... 3744209 - Sudden unexpected natural death in young persons. 15494969 - Linear parameters of normal and abnormal cava septi pellucidi: a post-mortem study. 21059669 - Worried no more: the effects of medication status on treatment response to a cbt group ... 15020389 - Learning with computerized guidelines in general practice?: a randomized controlled trial. 8294389 - Serotonin reuptake blockers for the treatment of obsessional jealousy. 3667939 - The comparative validities of six mmpi repression scales. 19052409 - Methotrexate toxicity presenting as ulceration of psoriatic plaques: a report of two ca... |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: Journal of child and adolescent psychopharmacology Volume: 20 ISSN: 1557-8992 ISO Abbreviation: J Child Adolesc Psychopharmacol Publication Date: 2010 Apr |
Date Detail:
|
Created Date: 2010-04-26 Completed Date: 2010-07-15 Revised Date: 2011-07-27 |
Medline Journal Info:
|
Nlm Unique ID: 9105358 Medline TA: J Child Adolesc Psychopharmacol Country: United States |
Other Details:
|
Languages: eng Pagination: 135-43 Citation Subset: IM |
Affiliation:
|
Center on Child and Family Outcomes, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington Street, Boston, MA 02111, USA. lleslie@tuftsmedicalcenter.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Child Child Abuse / statistics & numerical data Child Welfare / statistics & numerical data* Child, Preschool Drug Utilization / statistics & numerical data Female Health Surveys Humans Insurance Coverage / statistics & numerical data Male Psychotropic Drugs / therapeutic use* Risk Factors Time Factors |
| Grant Support | |
ID/Acronym/Agency:
|
R01MH072961/MH/NIMH NIH HHS; R03 MH082117/MH/NIMH NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Psychotropic Drugs |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Low-dose olanzapine monotherapy in girls with anorexia nervosa, restricting subtype: focus on hypera...
Next Document: Impact of Regulatory Safety Warnings on the Use of Antidepressants among Children and Adolescents in...